Detalles de la búsqueda
1.
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
Br J Haematol
; 165(4): 510-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24579926
2.
Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Adults with Inoperable or Metastatic Somatostatin Receptor-Positive Pheochromocytomas/Paragangliomas, Bronchial and Unknown Origin Neuroendocrine Tumors, and Medullary Thyroid Carcinoma: A Systematic Literature Review.
Biomedicines
; 11(4)2023 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37189646
3.
Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study.
Lancet Haematol
; 6(3): e122-e131, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30704923
4.
Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
J Clin Endocrinol Metab
; 96(12): 3741-9, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21994954
5.
Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
J Hematol Oncol
; 4: 3, 2011 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21232120
Resultados
1 -
5
de 5
1
Próxima >
>>